Growth Metrics

AbCellera Biologics (ABCL) Amortizatization of Intangibles (2020 - 2026)

AbCellera Biologics filings provide 7 years of Amortizatization of Intangibles readings, the most recent being $920000.0 for Q1 2026.

  • Quarterly Amortizatization of Intangibles changed 0.22% to $920000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $6.6 million through Mar 2026, down 91.43% year-over-year, with the annual reading at $6.6 million for FY2025, 91.51% down from the prior year.
  • Amortizatization of Intangibles hit $920000.0 in Q1 2026 for AbCellera Biologics, down from $1.8 million in the prior quarter.
  • Across five years, Amortizatization of Intangibles topped out at $73.5 million in Q4 2024 and bottomed at -$30.0 million in Q3 2024.
  • Average Amortizatization of Intangibles over 5 years is $6.8 million, with a median of $1.7 million recorded in 2024.
  • Peak annual rise in Amortizatization of Intangibles hit 1912.57% in 2024, while the deepest fall reached 1221.3% in 2024.
  • AbCellera Biologics' Amortizatization of Intangibles stood at $15.2 million in 2022, then plummeted by 75.98% to $3.7 million in 2023, then skyrocketed by 1912.57% to $73.5 million in 2024, then plummeted by 97.56% to $1.8 million in 2025, then tumbled by 48.8% to $920000.0 in 2026.
  • Per Business Quant, the three most recent readings for ABCL's Amortizatization of Intangibles are $920000.0 (Q1 2026), $1.8 million (Q4 2025), and $3.0 million (Q3 2025).